Physician profile
Ryan D Beardsley
NPI 1356870034
$825.17
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $92.58 · 2021: $110 · 2023: $457 · 2024: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365 · Education: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.51 |
| Education | $258.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $288.21 | 2023-2024 | Wegovy, Saxenda |
| Astellas Pharma US INC | $113.92 | 2023-2024 | Veozah |
| Pacira Pharmaceuticals Incorporated | $98.86 | 2021 | |
| Boston Scientific Corporation | $92.58 | 2020 | |
| Exeltis, USA INC. | $48.63 | 2023-2024 | Slynd |
| Ethicon US, LLC | $34.45 | 2023 | Enseal X1, Surgicel Nu-Knit |
| Hologic Sales and Service, LLC | $29.73 | 2021-2023 | Omni Hysteroscope |
| Pfizer INC. | $22.16 | 2023 | |
| Daiichi Sankyo INC. | $21.96 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $18.25 | 2023 | Gardasil 9 |
| Dexcom, INC. | $15.88 | 2024 | Dexcom G6 Transmitter |
| Minerva Surgical, INC | $15.80 | 2023 | |
| Coopersurgical, INC. | $14.52 | 2023 | Endosee |
| Organon LLC | $10.22 | 2023 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Beardsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.